| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |